Novonesis provided sales guidance for the year 2024. For the year, the company expects 5% to 7% organic sales growth.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
435.4 DKK | +0.72% | +4.06% | +17.33% |
May. 10 | NOVONESIS : Key segments outperform in average Q1 24 showing | |
May. 03 | Transcript : Novozymes A/S, Q1 2024 Sales/ Trading Statement Call, May 03, 2024 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+17.33% | 29.48B | |
-6.97% | 4.12B | |
-11.98% | 630M | |
-11.83% | 461M | |
-81.65% | 216M | |
-12.48% | 113M | |
-12.32% | 53.83M |
- Stock Market
- Equities
- NSIS B Stock
- News Novonesis A/S
- Novonesis Provides Sales Guidance for the Year 2024